SAM
Sectoral Asset Management Portfolio holdings
AUM
$151M
This Quarter Return
+0.25%
1 Year Return
+14.02%
3 Year Return
+79.35%
5 Year Return
+153.48%
10 Year Return
+511.68%
AUM
$520M
AUM Growth
+$3.52M
(+0.68%)
Cap. Flow
+$13.7M
Cap. Flow
% of AUM
2.64%
Top 10 Holdings %
Top 10 Hldgs %
23.77%
Holding
129
New
9
Increased
50
Reduced
34
Closed
11
Top Buys
| 1 |
Mineralys Therapeutics
MLYS
|
$9.6M |
| 2 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
$5.08M |
| 3 |
TSVT
2seventy bio
TSVT
|
$4.86M |
| 4 |
Treace Medical Concepts
TMCI
|
$4.7M |
| 5 |
Vera Therapeutics
VERA
|
$4.66M |
Top Sells
| 1 |
Exelixis
EXEL
|
$8.88M |
| 2 |
RCM
R1 RCM Inc. Common Stock
RCM
|
$6.05M |
| 3 |
iRhythm Technologies
IRTC
|
$4.59M |
| 4 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$4.22M |
| 5 |
Arrowhead Research
ARWR
|
$3.87M |
Sector Composition
| 1 | Healthcare | 95.06% |
| 2 | Industrials | 4.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Replimune Group
REPL
$449M
| $4.63M | 0.89% |
262,200
+65,700
| +33% | +$1.16M |
|
52
Thermo Fisher Scientific
TMO
$181B
| $4.59M | 0.88% |
7,965
| – | – |
|
53
Halozyme
HALO
$8.83B
| $4.48M | 0.86% |
117,400
-20,000
| -15% | -$764K |
|
|
RAIN
54
DELISTED
Rain Oncology Inc. Common Stock
RAIN
| $4.24M | 0.81% |
484,928
+466,128
| +2,479% | +$4.07M |
|
55
Zentalis Pharmaceuticals
ZNTL
$120M
| $4.02M | 0.77% |
234,000
+33,000
| +16% | +$568K |
|
|
SGEN
56
DELISTED
Seagen Inc. Common Stock
SGEN
| $3.92M | 0.75% |
19,350
-20,840
| -52% | -$4.22M |
|
|
IMGN
57
DELISTED
Immunogen Inc
IMGN
| $3.85M | 0.74% |
1,001,444
+197,500
| +25% | +$758K |
|
|
SILK
58
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $3.74M | 0.72% |
95,589
+11,000
| +13% | +$430K |
|
59
Biogen
BIIB
$20.5B
| $3.61M | 0.69% |
13,002
-350
| -3% | -$97.3K |
|
60
Abbott
ABT
$232B
| $3.57M | 0.69% |
35,248
+3,500
| +11% | +$354K |
|
61
Arcutis Biotherapeutics
ARQT
$1.96B
| $3.49M | 0.67% |
317,152
+113,300
| +56% | +$1.25M |
|
62
Bristol-Myers Squibb
BMY
$96.6B
| $3.47M | 0.67% |
50,000
| – | – |
|
63
Olema Pharmaceuticals
OLMA
$427M
| $3.46M | 0.66% |
995,909
-445,896
| -31% | -$1.55M |
|
64
Sarepta Therapeutics
SRPT
$1.91B
| $3.41M | 0.65% |
24,710
+21,910
| +783% | +$3.02M |
|
65
Outset Medical
OM
$238M
| $3.39M | 0.65% |
12,267
+2,934
| +31% | +$810K |
|
66
SPDR S&P Biotech ETF
XBI
$5.28B
| $3.3M | 0.64% |
43,353
+27,871
| +180% | +$2.12M |
|
67
Rocket Pharmaceuticals
RCKT
$351M
| $3.27M | 0.63% |
190,790
| – | – |
|
68
IQVIA
IQV
$30.6B
| $3.24M | 0.62% |
16,300
+1,200
| +8% | +$239K |
|
69
Medtronic
MDT
$119B
| $3.23M | 0.62% |
40,051
+8,500
| +27% | +$685K |
|
70
Rallybio
RLYB
$24.4M
| $3.15M | 0.61% |
551,937
-67,954
| -11% | -$388K |
|
71
Alignment Healthcare
ALHC
$3.2B
| $3M | 0.58% |
471,000
-78,000
| -14% | -$496K |
|
72
Cytokinetics
CYTK
$6.13B
| $2.95M | 0.57% |
83,850
+400
| +0.5% | +$14.1K |
|
73
Danaher
DHR
$140B
| $2.93M | 0.56% |
13,113
| – | – |
|
74
Moderna
MRNA
$9.21B
| $2.72M | 0.52% |
17,718
| – | – |
|
75
Edwards Lifesciences
EW
$47.7B
| $2.64M | 0.51% |
31,900
| – | – |
|